Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2346-74-9 | MDL No. : | MFCD00127840 |
Formula : | C6H5ClN4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UEZNSCCMEMUEMO-UHFFFAOYSA-N |
M.W : | 168.58 | Pubchem ID : | 94844 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.59 |
TPSA : | 43.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.42 cm/s |
Log Po/w (iLOGP) : | 1.62 |
Log Po/w (XLOGP3) : | 1.28 |
Log Po/w (WLOGP) : | 1.02 |
Log Po/w (MLOGP) : | -0.07 |
Log Po/w (SILICOS-IT) : | 1.12 |
Consensus Log Po/w : | 0.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.3 |
Solubility : | 0.851 mg/ml ; 0.00505 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.8 |
Solubility : | 2.7 mg/ml ; 0.016 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.34 |
Solubility : | 0.776 mg/ml ; 0.0046 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74.6% | Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.5 h; Reflux Stage #2: at 20℃; for 1 h; |
To a solution of 6-chloro-9H-purine (3.00 g, 20.0 mmol) in anhydrous THF (100 mL)cooled to 0 oC, 60percent sodium hydride (1.2 g, 30.0 mmol) were added portionwise. After the reaction suspension was refluxed for 0.5 hour in the ice bath, MeI (2.82 g,20.0 mmol) was added and the reaction mixture was stirred for 1 hour at room temperature. The mixture was diluted in 100 mL H2O and extracted with EtOAc (30 mL x 3). The combined organic layer was dried with anhydrous MgCl2 and the solvent was evaporated in vacuum. The crude solid was purified through a silica gel column, eluting with 20 percent ether acetate/petroleum. White solid was obtained in a yield of 74.6percent (2.50 g). ESI-MS m/z: 169.1 [M+H]+. 1H NMR (300 MHz, DMSO-d6): 3.72 (3H, s, CH3), 8.72 (1H, s, H-purine), 9.15 (1H, s, H-purine). |
[ 2382-10-7 ]
2,6-Dichloro-9-methyl-9H-purine
Similarity: 0.90
[ 79064-26-9 ]
9-Benzyl-2,6-dichloro-9H-purine
Similarity: 0.78
[ 2382-10-7 ]
2,6-Dichloro-9-methyl-9H-purine
Similarity: 0.90
[ 79064-26-9 ]
9-Benzyl-2,6-dichloro-9H-purine
Similarity: 0.78